172 related articles for article (PubMed ID: 25207681)
1. Differential expression of suppressor of cytokine signalling proteins in Behçet's disease.
Hamedi M; Bergmeier LA; Hagi-Pavli E; Vartoukian SR; Fortune F
Scand J Immunol; 2014 Nov; 80(5):369-76. PubMed ID: 25207681
[TBL] [Abstract][Full Text] [Related]
2. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
3. The expression of SOCS is altered in rheumatoid arthritis.
Isomäki P; Alanärä T; Isohanni P; Lagerstedt A; Korpela M; Moilanen T; Visakorpi T; Silvennoinen O
Rheumatology (Oxford); 2007 Oct; 46(10):1538-46. PubMed ID: 17726036
[TBL] [Abstract][Full Text] [Related]
4. Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis.
Liang X; He M; Chen T; Liu Y; Tian YL; Wu YL; Zhao Y; Shen Y; Yuan ZY
Int J Mol Med; 2013 May; 31(5):1066-74. PubMed ID: 23545584
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of SOCS1 methylation in patients with Behcet's disease.
Abdi A; Khabazi A; Sakhinia E; Alipour S; Talei M; Babaloo Z
Immunol Lett; 2018 Nov; 203():15-20. PubMed ID: 29990515
[TBL] [Abstract][Full Text] [Related]
6. SOCS1 gene expression is increased in severe pulmonary tuberculosis.
Masood KI; Rottenberg ME; Carow B; Rao N; Ashraf M; Hussain R; Hasan Z
Scand J Immunol; 2012 Oct; 76(4):398-404. PubMed ID: 22670716
[TBL] [Abstract][Full Text] [Related]
7. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
8. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
9. Suppressors of cytokine signalling in ankylosing spondylitis and their associations with disease severity, acute-phase reactants and serum cytokines.
Chen CH; Chen HA; Liao HT; Liu CH; Tsai CY; Chou CT
Clin Exp Rheumatol; 2016; 34(1):100-5. PubMed ID: 26812031
[TBL] [Abstract][Full Text] [Related]
10. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
11. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
Zou J; Ji DN; Shen Y; Guan JL; Zheng SB
Ann Clin Lab Sci; 2016 Dec; 46(6):675-679. PubMed ID: 27993883
[TBL] [Abstract][Full Text] [Related]
12. Expression of SOCS1 and SOCS3 is altered in the nasal mucosa of patients with mild and moderate/severe persistent allergic rhinitis.
Kim TH; Kim K; Park SJ; Lee SH; Hwang JW; Park SH; Yum GH; Lee SH
Int Arch Allergy Immunol; 2012; 158(4):387-96. PubMed ID: 22487676
[TBL] [Abstract][Full Text] [Related]
13. The role of TLR2 and 4 in Behçet's disease pathogenesis.
Seoudi N; Bergmeier LA; Hagi-Pavli E; Bibby D; Curtis MA; Fortune F
Innate Immun; 2014 May; 20(4):412-22. PubMed ID: 23940075
[TBL] [Abstract][Full Text] [Related]
14. Increased SOCS expression in peripheral blood mononuclear cells of end stage renal disease patients is related to inflammation and dialysis modality.
Rastmanesh MM; Braam B; Joles JA; Boer P; Bluyssen HA
Eur J Pharmacol; 2009 Jan; 602(1):163-7. PubMed ID: 19041303
[TBL] [Abstract][Full Text] [Related]
15. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.
Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H
J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokines, chemokines, and chemokine receptors in oral ulcers of patients with Behcet's disease (BD) and recurrent aphthous stomatitis is Th1-associated, although Th2-association is also observed in patients with BD.
Dalghous AM; Freysdottir J; Fortune F
Scand J Rheumatol; 2006; 35(6):472-5. PubMed ID: 17343257
[TBL] [Abstract][Full Text] [Related]
17. CD11c is upregulated in CD8+ T cells of patients with Behçet's disease.
Park YJ; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S86-S91. PubMed ID: 27309860
[TBL] [Abstract][Full Text] [Related]
18. Diversity of gammadelta T cells in patients with Behcet's disease is indicative of polyclonal activation.
Freysdottir J; Hussain L; Farmer I; Lau SH; Fortune F
Oral Dis; 2006 May; 12(3):271-7. PubMed ID: 16700735
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Potential for Targeting the Suppressor of Cytokine Signalling-1 Pathway for the Treatment of SLE.
Sukka-Ganesh B; Larkin J
Scand J Immunol; 2016 Nov; 84(5):299-309. PubMed ID: 27781323
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of SOCS3 in monocytes and SOCS1 in lymphocytes correlates with progressive loss of renal function and cardiovascular risk factors in chronic kidney disease.
Rastmanesh MM; Bluyssen HA; Joles JA; Boer P; Willekes N; Braam B
Eur J Pharmacol; 2008 Sep; 593(1-3):99-104. PubMed ID: 18656467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
